Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

Filter conferences

Pharma Australia VIRTUAL 2020

Pharma Australia VIRTUAL 2020


Date of beginning

Monday, 26 October 2020


3 days




Saskia Burbach


This email address is being protected from spambots. You need JavaScript enabled to view it.

Expected participants



Now more than ever, Pharma is called upon to lead the way to recovery from this crisis and prepare for the future. Australia's old operating model has been swept away by unprecedented environmental, economic, and public health disasters. In its place a new virtual age is propelled to maturity. But with accelerated change comes instability, and although innovative ideas suddenly have the space to grow, we have to ask: " Have we built a foundation that can support our new normal?" As commercial, marketing and medical strategies are upended, the structures we hastily built to shelter from disaster have become long-term models for the way we work. This new digital scaffolding is showing us the future of pharma, but in order to thrive, we now need to come together to shore-up the foundations and ensure we understand and implement the best-practices developed both in and out of industry for virtual communications, customer experience, medical, access, and partnership models. This is why Reuters Events Pharma Australia VIRTUAL is bringing together the top strategic and implementation leaders from across Australian Pharma to be architects for our collective future and give us the tools we need to rebuild in the image of the new normal. On Monday October 26, 2020 at 9:00 am (ends Wednesday October 28, 2020 at 6:00 pm). Speakers: Elizabeth de Somer, CEO Medicines Australia , Liz Chatwin, Country President Australia and NZ, AstraZeneca, Chris Temple, GM and VP, Abbvie, Christi Kelsey, GM, GSK, Dr Jason Gavin, GM Australia and NZ, Leo Pharma , Stefan Miljkovic, Head of Digital Transformation and Innovation, Novartis, Peter Said, Head of Patient Engagement Asia Pacific Region, Bayer, Nicole Millis, CEO, Rare Voices Australia